PPT-Performance of Measles-Rubella Surveillance Indicators

Central America Cuba Mexico Haiti and Dominican Republic 20182022 Source ISIS and country reports Data as of 3 March 2023. Susan E. Reef, MD. Global Measles and Rubella Management Meeting. March 15, 2011. Outline. Background. Terms of Reference. Opportunities to align with measles strategies. Recommendations from the WG. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. WHO Western Pacific Region. UNICEF East Asia and Pacific Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 2003. : Measles elimination to be used to strengthen routine immunization . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . . Mona Aryal. HOD, Health Service Department. Nepal Red Cross Society. National Headquarter. . Nepal Red Cross Society’s Initiative. Vision: . to . provide immediate relief to human suffering and reduce vulnerability, under the Fundamental Principles of the Red Cross, . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Programme:Update. Stefano Malvolti . September 2015, Washington DC. Page: . 1. Reach every child. . MANY . REGIONS AT . RISK . / OFF . TRACK FROM MEASLES ELIMINATION GOALS. Source: . WHO . Source: WHO/UNICEF coverage estimates . Measles and Rubella Annual Partners Meeting, September 15-16 2015. Background. The MRI FRR is developed by the M&RI FRR/RMAWG. Country population data is drawn from UNDP estimates. Vaccine type and timing of SIAs is from countries . Hotel Royal, Geneva, Switzerland, 21-23 June 2016. Paul Rota,. Measles, Mumps, Rubella, Herpesviruses Laboratory Branch, CDC . par1@cdc.gov. . National Center for Immunization & Respiratory Diseases. to destroy the virus. However, as with all vaccines, 100% protection against measles, mumps and rubella cannot be guaranteed. Also itThe chance of a severe reaction from M-M-R II is very small, but MEA R) VACCINE What is the measles, mump and rubella (MMR) vaccine? The MMR vaccine protects against three diseases: measles, mumps and rubella (german measles). The vaccine is approved by He alth C ALL students are REQUIRED to provide proof of immunity to measles, mumps, and rubella (“MMR”). Before students may enroll in classes, NAU requires documentation of ONE of the following: • Tw Accelerating Progress Towards Measles and Rubella Elimination. 23 June 2016. Geneva. , Switzerland. Minal K. Patel WHO HQ IVB/EPI. Background. Growing demand for periodic cross-sectional surveys to identify population immunity gaps.